• (photo courtesy of Bayer)

    Bayer to Close Mishawaka Facility

    Germany-based pharmaceutical company Bayer has announced plans to close its customer logistics service center in Mishawaka. The company says the closure will take place over an 18-month transition period and will affect nearly 200 employees.

  • Lilly Completes $8B Acquisition

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has completed its $8 billion acquisition of Loxo Oncology Inc. (Nasdaq: LOXO) in Connecticut. Loxo Chief Executive Officer Josh Bilenker says the deal will allow the company to realize the full value of its pipeline of medicines.

  • BASi Profit Falls Despite Revenue Jump

    West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is reporting a fiscal first quarter net loss of $85,000, compared to net income of $26,000 during the same period the previous year. Despite the drop, the company says quarterly revenue increased more than 60 percent.

  • Russ Fellows is the project manager for Roche Academy.

    Roche Academy Aims to Fill Need For Talent

    The University of Indianapolis and Roche Diagnostics are partnering on an effort to fill a talent gap. The first cohort for Roche Academy has begun and the university says the goal is to solve the talent pipeline for biomedical equipment technicians. The academy provides a customized curriculum for the cohort of eight students, as well as a summer internship, that provides real-world training to prepare students for high-demand positions at Roche.

  • Elanco went public in September 2018.

    Lilly Reveals Plan to Offload Elanco Stock

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced plans to divest its remaining interest in Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN). The pharmaceutical giant retained a more than 80 percent ownership interest in Elanco, following the company's Initial Public Offering in September.

  • Cook Group in Bloomington is one of the largest life sciences companies headquartered in the state.

    Georgia Woman Wins $3M Verdict Against Cook Medical

    A federal jury in Indianapolis has awarded $3 million to a Georgia woman who claimed an intravenous filter made by Bloomington-based Cook Medical was defective. Tonya Brand says she suffered medical complications after the filter deteriorated inside her body.

  • Lilly says quarterly revenue increased 4.5 percent to $6.4 billion.

    Lilly Returns to Profit

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is reporting fourth quarter net income of $1.1 billion, compared to a loss of $1.7 billion the previous year, when earnings were impacted by U.S. tax reform. The company is also cuttings its revenue and profit forecast for 2019, due in part to disappointing results from a Phase 3 study of cancer drug Lartruvo. Lilly says quarterly revenue increased 4.5 percent to $6.4 billion, topping estimates. The company cites higher sales of...

  • (image courtesy of the IU School of Medicine)

    IU Med School Hits Record NIH Funding

    Researchers at the Indiana University School of Medicine received a record amount of funding from the National Institutes of Health in 2018. The school says nearly $150 million was awarded, marking a 10 percent increase over the previous year.

  • Rehab Medical Merges With Wound Care Company

    Indianapolis-based Rehab Medical Inc. has announced a merger with medical device manufacturer Cork Medical, also based in Indy. Financial terms of the deal are not being disclosed, however Rehab Medical tells Inside INdiana Business it plans to add 50 jobs by the end of the year.

  • Lilly Acquisition Moving Forward

    Indianapolis-based Eli Lilly and Co.'s (NYSE: LLY) $8 billion acquisition of Loxo Oncology Inc. (Nasdaq: LOXO) has cleared its first hurdle. Lilly says the deal has made it past the waiting period under the Hart-Scott-Rodino Antitrust Act. The acquisition was first announced in early January. Lilly says the deal will add precision medicines to its oncology portfolio.

  • Zimmer Biomet Swings to Huge Loss

    Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) is reporting a fourth quarter net loss of $903 million, compared to net income of $1.2 billion during the same period the previous year. The medical device manufacturer says the loss included goodwill impairment and litigation charges.

  • Crew Engineer Kasey Hilton points to a rock she collected for crew geologist Ellen Czaplinski.

    Purdue Students Move To ‘Mars’ For Two Weeks

    A team of six Purdue University students and alumni is readjusting to life on planet Earth after spending two weeks on “Mars.” Although they didn’t travel to the real Red Planet, the crewmembers lived in isolation inside a small research station in a remote area of Utah.

  • The test involves connecting the horse's airways to two different tanks; one with positive pressure and the other with negative (like a vacuum).

    Purdue Asthma Test Helps Heal Racehorses

    Indiana is the only place in the world with a cutting-edge respiratory testing device for horses. Veterinarians and engineers at the Purdue University College of Veterinary Medicine developed the tool to bring clarity to an elusive condition. 

  • IU Philanthropic Venture Fund Wraps First Year of ‘Perpetual’ Model

    The Indiana Philanthropic Venture Fund (IU PhV) is on the doorstep of its one-year anniversary and, although not limited to the life sciences, it has funneled $1.6 million into the sector’s early-stage Indiana-based companies. 

  • The InCore Lapidus System, an orthopedic device for the foot, contributed to sales momentum in 2018.

    Nextremity Touts Success With New Strategy

    Warsaw-based Nextremity Solutions, Inc. says 2018 was a critical year of validation. The orthopedic company changed its business model in 2016—moving away from its roots as a traditional startup and becoming a strategic commercialization organization. 

  • Life Sciences Company Makes Acquisition From Silicon Valley

    Indianapolis-based Beckman Coulter Life Sciences is adding to its portfolio. The company has acquired California-based liquid handling company Labcyte, though financial details were not immediately disclosed. 

  • IBRI Project Leads to Disease Discovery

    A collaborative research project involving the Indiana Biosciences Research Institute has led to the discovery of a new disease. The IBRI says the monogenic disease, known as DHPS Deficiency, can lead to neurodevelopmental delay and seizures. 

  • Lilly 'Disappointed' by Cancer Drug Study

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced what it calls disappointing results of a study of a new cancer drug. The pharmaceutical giant says the Phase 3 study of Lartruvo, which aims to treat patients with advanced or metastatic soft tissue sarcoma, did not meet its primary endpoints.

  • Cook Medical Partnering on Snoring Device

    Bloomington-based Cook Medical has announced a sales and marketing agreement with Zelegent Inc. in California. Cook says the partnership aims to enhance treatment options for patients suffering from snoring.

  • Lilly's acquisition is the latest in an effort to strengthen its cancer treatment portfolio.

    Lilly Announces $8B Acquisition

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced an $8 billion deal to acquire Loxo Oncology in Connecticut. Lilly says the deal adds precision medicines to its oncology portfolio through Loxo's pipeline of medicines for patients with certain types of cancers. The Indy drugmaker says the acquisition would be the largest in its ongoing effort to strengthen its cancer treatment portfolio. Loxo's pipeline is focused on cancers that involve single gene abnormalities that can...

  • (photo courtesy of Sentry BioPharma Services)

    Commission OKs Two Indy West Side Projects

    The Indianapolis Metropolitan Development Commission has approved tax abatement for two projects on the city's west side totaling nearly $11.5 million. According to documents filed with the city, the developments would create and retain nearly 60 jobs. Indianapolis-based Sentry Ventures LLC is planning to invest nearly $9 million to build and equip a 30,000-square-foot addition to its existing facility and Japan-based Ryoei USA Inc. is looking to invest $2.5 million to build a...

  • (Image courtesy of Endocyte)

    Endocyte Shareholders Approve Acquisition

    The shareholders of West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) have approved the previously-announced $2.1 billion acquisition agreement with Switzerland-based pharmaceutical company Novartis AG. The company says the deal is expected to close Friday.

  • BASi Swings to Full-Year Loss

    West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is reporting a fiscal full-year net loss of $194,000, compared to net income of $884,000 the previous year. The company says the results are due in part to one-time costs associated with its July acquisition of Missouri-based Seventh Wave Laboratories LLC.

  • A Notre Dame researcher suspects firefighters' protective clothing sheds chemicals that are linked to cancer. (photo courtesy: International Association of Fire Chiefs)

    The Mystery of Cancer in Firefighters: Two Indiana Researchers Uncover Clues

    There’s a lot of conjecture about cancer in the world of firefighting, but a crescendo of anecdotal—and scientific—evidence is driving two Indiana researchers to search for answers. 

  • Ladisch and Purdue PhD student Jessica Zuponcic (left) say the instrument could catch elusive bacteria that sneak through current methods.

    Purdue Method Could Keep Lettuce Safe

    Romaine has returned to store shelves after a recent E. coli outbreak stopped salads at both grocers and restaurants. Science is partly to blame; the U.S. Food and Drug Administration (FDA) recalled all romaine as a broad safety measure, because detecting pathogens such as E. coli takes time in the lab—up to three days in some cases. 

  • CEO Ponsi Trivisvavet says Inari aims to revive plants' natural genetic diversity that has been "lost in the system."

    Inari Chooses Indiana to Help Build Better Seeds

    ‘How do we feed 9 billion people by 2050?’ is a common rallying cry—and foreboding challenge—within the agricultural community. But a young company from the Boston area—now opening its next operation at Purdue Research Park in West Lafayette—says the right question to ask is, ‘How do we feed the world without destroying the planet?’ 

  • The company is projecting 2019 revenue between $25.3 billion and $25.8 billion.

    Lilly Issues 2019 Guidance

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced 2019 financial guidance, with projected revenue and adjusted profit above analyst expectations. The company says the growth is driven by demand for newer medicines including Trulicity, for diabetes, and psoriasis drug Taltz. The company is projecting 2019 revenue between $25.3 billion and $25.8 billion, and earnings per share between $5.52 and $5.62. Chief Executive Officer David Ricks says, while he's happy with...

  • Lilly Acquires Pre-Clinical Program

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced an agreement with Massachusetts-based Hydra Biosciences. The company says it has acquired all assets related to a pre-clinical program from Hydra, though financial terms of the deal are not being disclosed.

  • BioCrossroads Looking to the Future During Transition

    The incoming interim president and chief executive officer of BioCrossroads says the transition in leadership will be a smooth one. The state's life science initiative announced Wednesday longtime CEO David Johnson is leaving to continue his role as CEO of the Central Indiana Corporate Partnership on a full-time basis. Norah Doherty will assume the interim position at the beginning of the year and says BioCrossroads continues to look to the future.

  • 16 Tech says the anchor building will ultimately house about 400 employees.

    Work Begins on 16 Tech's First Building

    16 Tech developers have officially broken ground on the innovation district's first building, marking the beginning of an ambitious 10-year project. The $30 million Advanced Research and Innovation building is fully-leased and will anchor the 60-acre development. The facility, which will house the Indiana Biosciences Research Institute, Central Indiana Corporate Partnership and Indiana University School of Medicine researchers, is set to be complete in mid-2020.

  • BioCrossroads CEO Moving On

    The chief executive officer of the state's life sciences initiative is stepping down. BioCrossroads says David Johnson, who has led the organization for 14 years, is leaving at the end of the year to serve as president and CEO of the Central Indiana Corporate Partnership on a full-time basis. The CICP is the parent organization of Indiana's six talent and industry sector initiatives, including BioCrossroads. Johnson was elected president and CEO of the CICP in 2012 and has since led...

  • Mark Throdahl is CEO of OrthoPediatrics. (photo courtesy Nasdaq)

    OrthoPediatrics Making Stock Offer

    Warsaw-based OrthoPediatrics Corp. (Nasdaq: KIDS) has begun a public stock offering. The pediatric medical device manufacturer is looking to raise up to nearly $47 million as a result of the offering, which is expected to close Tuesday.

  • Notre Dame, IBRI Form 'Strategic Alliance'

    The University of Notre Dame has signed a strategic alliance agreement with the Indiana Biosciences Research Institute in Indianapolis. The IBRI says the agreement will enable both parties to "work together on research covering significant health issues in Indiana and around the world."

  • BioCrossroads Receives Fairbanks Foundation Grant

    BioCrossroads' educational efforts have received a boost from a grant from the Richard Fairbanks Foundation. The organization received a $1.48 million grant to advance opportunities in Indiana's life sciences and healthcare sectors.

  • (photo courtesy of Catalent)

    Catalent Expanding in Bloomington

    New Jersey-based Catalent Inc. (NYSE: CTLT) has announced plans to grow its Bloomington operations. The company says it will invest nearly $14 million to expand its biologics packaging capacity at its Monroe County manufacturing facility and create 36 jobs. Catalent entered the Bloomington market in 2017 with its $950 million acquisition of Cook Pharmica. The company says it will construct a 15,000-square-foot addition that will include...

  • Rick Sasso (photo courtesy of Indiana Spine Group)

    Indiana Surgeon Wins $112M Verdict

    A jury in Marshall County has awarded what is being called one of the largest verdicts in Indiana history to an Indianapolis spine surgeon and inventor. Rick Sasso would receive more than $112 million in royalties and interest which he claimed he was owed by Minnesota-based medical device company Medtronic PLC (NYSE: MDT).

  • The Apple Watch will track time spent sitting or standing, number of steps and even heartrate.

    Hoosiers Help Test Apple Watch For Joint Replacement Recovery

    The Apple Watch is no longer just a fitness tracker—a new app developed by Warsaw-based Zimmer Biomet Holdings, Inc. is like “a live-in physical therapist,” says one Hoosier orthopedic surgeon. 

  • Mills says more than 500 of the modified bandage kits have been distributed in Kenya.

    Purdue Alum Creates Bandages to Save Lives in Kenya

    A skin infection called Kaposi Sarcoma—easily treated in the U.S.—claims about one million lives each year in Kenya. The situation puzzled a Purdue University pharmacy alum and motivated him to create a medicated bandage that is now being used in the African nation. 

  • Lafontant says DePauw’s small size will provide students more hands-on time with the equipment, which the school is ordering now.

    DePauw Gets Microscopes ‘Schools Like DePauw Don’t Have’

    Powerful imaging equipment typically found at major research institutions will soon be part of the  DePauw University campus. The school is purchasing a handful of cutting-edge light and electron microscopes.

  • Conley says AcceLINX leverages the resources in the region to help entrepreneurs and early-stage companies be successful.

    AcceLINX Boosting Ortho Innovators

    The Orthopedic Capital of the World is already unique as home to the highest concentration of resources for the design, development and manufacturing of musculoskeletal products in the world—but local leaders say the region’s approach to innovation is also one-of-a-kind. 

  • Carter Cliff is the CEO of Vascugen. (photo courtesy of Indiana University)

    IU Fund Makes Another Medical Investment

    The Indiana University Philanthropic Venture Fund has announced support for an Indianapolis-based regenerative medicine company. While specific numbers are not being released, the fund says it has invested in Vascugen Inc., which focuses on finding therapies to repair human tissue damaged by reduced blood flow due to disease or injury.

  • NICO Corp. makes a variety of neurosurgical devices.

    Medical Device Company Secures $12.5M in Funding

    Indianapolis-based NICO Corp. has completed a $12.5 million Series B round of funding. The neurosurgical medical device manufacturer says the funding will support a variety of priorities, including new product development and commercialization, as well as additional clinical studies.

  • Indiana Attorney General Curtis Hill

    State Files Suit Against Pharmaceutical Company

    Indiana Attorney General Curtis Hill has filed suit against a Connecticut-based pharmaceutical manufacturer. The lawsuit alleges Purdue Pharma, which makes opioid products such as OxyContin, played a key role in the state's opioid crisis by misrepresenting the risks and benefits of opioids.

  • (Image courtesy of Endocyte)

    Endocyte Loss Narrows Amid Pending Acquisition

    West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is reporting a third quarter net loss of $12.6 million, compared to a net loss of $23.3 million during the same period a year earlier. The biopharmaceutical company is in the midst of a proposed $2.1 billion acquisition by Switzerland-based Novartis AG, which is expected to close in the first half of next year. The deal is considered the largest of its kind ever for an Indiana life sciences company.

  • IBRI Details Medical Data Collaboration

    The Indiana Biosciences Research Institute in Indianapolis has announced a partnership with a global information technology consulting company. Massachusetts-based Virtusa Corp. (Nasdaq: VRTU) says the collaboration will involve analyzing synthetic medical data, which isn't subject to the same privacy regulations as real-world data sets, to accelerate research on diseases like diabetes. The collaborative analyses, IBRI and Virtusa say, will use...

  • (Image courtesy of Indiana University.)

    Don Brown to Headline Life Sciences Presentation

    One of the biggest names in the state's technology scene will deliver a keynote address Friday at a life sciences industry event. Don Brown, who founded and sold Software Artistry and Interactive Intelligence and launched a third company in 2016, LifeOmic, will headline The Changing Business of Healthcare conference at the Roche Diagnostics corporate headquarters in Indianapolis. The event is part of...

  • The foundry spans 26,000 square feet in the Purdue Research Park.

    Cambridge Ag Company Picks Purdue Research Park

    A Boston-based seed development and plant breeding company is expanding into the Purdue Research Park. Inari will open what it calls the world's first Seed Foundry at the complex. The company says the work done there can help "revolutionize the seed industry" and create a more resilient and sustainable food system. Inari Senior Vice President of Operations Mark Stowers says the 26,000 square-foot facility will ultimately house about 50 people, but adds there is plenty...

  • (Image courtesy of Ivy Tech Community College.)

    Dozens of Employers to Attend Fort Wayne Job Fair

    Nearly 70 employers are expected to attend a jobs event Wednesday in northeast Indiana. Ivy Tech Community College Fort Wayne is hosting the 2018 Fall Career Fair, which is open to the public and will feature opportunities to talk with companies in fields including heath care, manufacturing and nonprofit. In addition to meeting with employers, Ivy Tech says the event will include free professional headshots for jobseekers to use on LinkedIn profiles. Employers expected to be in...

  • Lilly Reports Higher Earnings

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is reporting third quarter net income of $1.42 billion, compared to $1.1 billion during the same period last year. The report is the pharmaceutical maker's first since Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) spun out as an independent company. Chief Executive Officer David Ricks characterized the results as strong and adding revenue guidance was increased. For the full year, Lilly expects revenue to be...

  • Elanco says third quarter revenue hit $761.1 million, a 9 percent increase over last year.

    Elanco Swings to Profit in First Post-IPO Earnings

    Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) is reporting its first set of earnings since spinning off from Eli Lilly and Co. (NYSE: LLY) earlier this year. The company is reporting third quarter net income of $60.2 million, compared to a loss of $20.7 million during the same quarter last year. Elanco says revenue hit $761.1 million for the third quarter, which is a 9 percent increase compared to the third quarter of 2017. The company credits a...

  • Lilly says it has made a $15 million equity investment in NextCure.

    Lilly, Maryland Company Ink $40M Partnership

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has entered into a multiyear partnership with NextCure Inc. in Maryland. As part of the at least $40 million deal, the companies will work together on immuno-oncology therapies through NextCure's FIND-IO platform. NextCure will receive $25 million from Lilly upfront, and will be eligible for milestone and royalty payments if Lilly can develop and commercialize new cancer therapies through the collaboration. The Indianapolis company has...
  • BioCrossroads awarded Regenstrief Institute (left) top prize. DigiBiomarkers' technology (right) won second place.

    First ‘Inject Tech Challenge’ Crowns Winners

    Digital technology is defining the future for Indiana’s life science companies, say local leaders. The state’s life sciences initiative BioCrossroads is fanning the flame of entrepreneurs dreaming up the digital health solutions of tomorrow. 

  • Anderson 'Perfect Environment' For Italpollina Operation

    The head of an Italian agbiosciences company that has established its North American headquarters in Anderson calls Indiana "the perfect environment for business." During a ribbon cutting ceremony Friday on a former General Motors plant site, Italpollina Chief Executive Officer Luca Bonini said his company is already working on a second production phase that could open the door for exports from the Madison County operation. The company now has...

  • Elanco Partners With Danish Company

    Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) has announced a global research and development partnership with Denmark-based Novozymes A/S. Elanco says the collaboration aims to develop nutritional health products for beef cattle and dairy cows throughout the world.

  • (Images of Luca Bonini, Susan Wasson and Brian Emerick supplied by AgriNovus Indiana.)

    Agbiosciences Leaders Join AgriNovus Indiana Board

    AgriNovus Indiana has added three to its board of directors. Chief Executive Officer Beth Bechdol says the new board members represent a diverse mix of backgrounds and industries within the agbiosciences sector. The new board members are...

  • Joe Wheat founded MiraVista in 2002.

    Diagnostics Developer Plans Indy HQ Expansion, Jobs

    Indianapolis-based MiraVista Diagnostics LLC has announced a $5.3 million expansion. The fungal disease testing company says it plans to add up to 31 jobs by 2021 and double the size of its headquarters. MiraVista currently employs 44 and says hiring is expected to begin next year for positions including customer service representatives, laboratory technicians, research scientists and sales and marketing associates. The new positions are expected to pay...

  • Venture Winners Take Aim at Diabetes, Disease Outbreaks

    Patients who have undergone a diabetes-related amputation currently face a terrifying prognosis: only 50 percent survive one year after the procedure. Notre Dame startup SalvePeds believes it has uncovered a drug that will save the limbs and lives of people with diabetes. Purdue University startup OmniVis also aims to save lives by battling disease outbreaks in low-resource areas. 

  • Mend Medical executive team (left to right): Bryce Isch, Ben Joseph and Seth Nash.

    Investment Firm Aims to ‘Mend’ Healthcare Industry

    A unique investment firm in Fort Wayne dedicated to “healing healthcare” is now open for business—with a special focus on northern Indiana. 

  • Nallathamby and his team are developing a double-sided nanoparticle.

    Researcher Tweaks T-Cells for Tumors

    A new cutting-edge cancer treatment called CAR T-cell therapy—which requires only a single treatment—is curing patients with certain lymphomas and blood cancers, but researchers are struggling to translate the treatment for solid tumors. 

  • Katherine Pawelczak is vice president for research at NERx Biosciences. (photo courtesy of Indiana University)

    IU Fund Invests in Drug Company

    The Indiana University Philanthropic Venture Fund has announced plans to invest $500,000 in an Indianapolis-based drug development company. NERx Biosciences says the investment will further development of its first-in-class targeted cancer therapy drug. 

  • (Image courtesy of Lilly)

    Lilly Details Collaboration That Could Grow Exponentially

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced a $100 million global licensing and research collaboration. The company will partner with Massachusetts-based Dicerna Pharmaceuticals Inc. (Nasdaq: DRNA) on potential cardio-metabolic disease, neurodegeneration and pain treatments. The deal also involves a $100 million equity investment from Lilly. More than 10 targets are expected to be involved. Lilly says Dicerna could receive...

  • Profit Jumps For Zimmer Biomet

    Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) is reporting third quarter net income of $162 million, up from $98.8 million during the same period last year. Chief Executive Officer Bryan Hanson says the earnings reflect the company's sustained progress in a number of areas. 

  • Program Offers Rehab to Workers Who Fail Drug Test

    As opioid addiction issues continue to ravage Hoosier communities and the workforce, a global manufacturer with multiple Indiana locations is offering rehabilitation assistance for potential employees who fail pre-hiring drug screenings. Belden, which has had a longtime presence in Richmond, has launched Pathways to Employment in response to a tripling of drug test failures and an ongoing need for talent. VP of HR Leah Tate says more than two-thirds of participants are still with it.

  • Cook Regentec Focused on Breakthroughs, Collaboration

    Bloomington-based Cook Regentec has opened its first facility in Indianapolis. The company has transformed an old beer warehouse into space at the high-profile 16 Tech innovation district. Part of the space will be dedicated to what the regenerative medicine therapy incubator and accelerator is calling The Collaboratory, where its scientists, engineers and product developers will partner with Indiana University School of Medicine researchers.

  • (Image provided by Lilly.)

    Positive Studies Push Promising Lilly Treatment Forward

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has announced a key potential treatment is moving closer to market. Taltz, which is being tested for use by patients with a type of arthritis that causes inflammation in the spine, has met its targets on two late-stage studies. Lilly says the positive results clear the way for it to submit the ankylosing spondylitis treatment for U.S. regulatory approval later this year. VP of Immunology Development Lotus Mallbris says...

  • BASi Begins Mount Vernon Expansion

    West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) has broken ground on the expansion of its GLP toxicology facility in Mount Vernon. The company says the project will more than double the facility’s current capacity.

  • Mark Throdahl is CEO of OrthoPediatrics. (photo courtesy Nasdaq)

    OrthoPediatrics Lands FDA Clearance

    Warsaw-based OrthoPediatrics Corp. (Nasdaq: KIDS) has received clearance from the U.S. Food and Drug Administration for its newest surgical system. The company says the RESPONSE System is designed to treat smaller stature young patients with complex scoliosis. 

  • DowDuPont Paints Picture of Ag Spin-Out

    Michigan-based DowDuPont Inc. is providing a detailed look at the scope of its agriculture spin-out Corteva Agriscience. The independent company, which will have a significant presence in Indianapolis, will be made up of a combination of Indianapolis-based Dow AgroSciences, DuPont Pioneer and DuPont Crop Protection. The spin is expected to take place June 1. In a notice to shareholders included in a U.S. Securities and Exchange Commission filing, CEO James Collins said...

  • (Image courtesy of Endocyte)

    $2.1B Endocyte Deal a Record-Breaker

    A veteran of Indiana's life sciences industry says the proposed blockbuster sale of West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) is good for the ecosystem in the state. Switzerland-based Novartis AG has signed an agreement to acquire Endocyte for $2.1 billion, which BioCrossroads Project Director Brian Stemme says is "by far" the largest-ever acquisition of an Indiana life sciences company. The deal still faces regulatory and shareholder hurdles.

  • Mike Sherman is CEO of Endocyte.

    Endocyte, Novartis Ink $2.1B Merger Agreement

    West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) has announced a merger agreement with a global pharmaceutical giant. The deal with Switzerland-based Novartis AG is valued at $2.1 billion and still requires shareholder approval. Until regulatory and other approvals are met, Endocyte will remain independent. The proposed merger of Endocyte into Novartis is slated to be complete in the first half of next year. Endocyte develops targeted cancer therapies and earlier this...

  • Zimmer Biomet Partnering With Apple

    Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has announced a partnership with Apple Inc. (Nasdaq: AAPL) to assist patients undergoing knee and hip replacement surgeries. Zimmer Biomet has developed an app for the iPhone and Apple Watch designed to improve the connection between patients and their surgical care teams.

  • Ben Forrest is CEO of Olio.

    Tech Startup Aims to Cut Out Medical 'Stumbling Block'

    As healthcare continues to evolve, a Carmel-based tech startup is rising to meet one rapidly-changing facet of the industry's business model. Olio develops software that it says helps providers at every stage of care communicate more effectively. CEO Ben Forrest says the platform his growing company has developed overcomes the traditional stumbling block of sharing information on a patient's recovery among multiple caregivers, health systems and facilities from start-to-finish.

  • Shekhar (left) and BioCrossroads CEO David Johnson (right)

    BioCrossroads Announces Watanabe Winner, New Seed Fund

    Indiana University Associate Vice President for Clinical Affairs Anantha Shekhar is the 2018 Watanabe Life Sciences Champion of the Year. BioCrossroads made the announcement today at its annual Life Sciences Summit in Indianapolis. Shekhar is leading the $120 million Precision Health Grand Challenges effort. Also at today's event, the state's life sciences initiative announced the $9 million Indiana Seed Fund III, focused on life sciences, health IT and agbiosciences companies.

  • Officials from the Regenstrief Institute accepted the first place prize in the Inject Tech Challenge. (photo courtesy of Regenstrief Institute)

    Life Sciences Summit Competition Winners Unveiled

    BioCrossroads has unveiled the winners of two competitions at the 2018 Indiana Life Sciences Summit. The events include the inaugural Indiana Inject Tech Challenge, which focuses on the creation of new technologies designed to improve patient outcomes, as well as the BioCrossroads New Venture Competition.

  • (photo courtesy of DePauw University)

    Grant to Establish Biomedical Imaging Center at DePauw

    A three-year, $527,000 grant from the Buehler Family Foundation will establish the Buehler Biomedical Imaging Center at DePauw University. The school says the center will give students access to cutting-edge equipment as they study regeneration biology, wound healing, and the neuroscience of addiction.

  • (photo courtesy of BioCrossroads)

    Life Sciences Summit to Kick Off

    Indiana's life sciences initiative will this week host its annual two-day gathering focusing on the future of the life sciences sector. The 2018 Indiana Life Sciences Summit will feature keynote addresses from representatives of industry companies such as LifeOmic, Eli Lilly and Co. (NYSE: LLY), and Roche Diagnostics.

  • First 16 Tech Building Fully Leased

    The first new building in Indianapolis' innovation district is fully leased. 16 Tech developers say the $30 million research and office facility will house the Indiana Biosciences Research Institute, Central Indiana Corporate Partnership and Indiana University School of Medicine researchers. Construction on the anchor facility is set to begin later this year. IBRI will take more than 67,000 square feet of space on the first three floors of the building. The institute aims to...

  • IU neurologist Liana Apostolova will lead the study. (photo courtesy Indiana University)

    IU-Led Study Lands Major NIH Grant

    A team of researchers led by an Indiana University School of Medicine neuroscientist has received the largest single grant from the National Institutes of Health. The nearly $45 million grant will fund a five-year national research study on a rare form of Alzheimer’s disease. The study is being led by IU neurologist Liana Apostolova. The Longitudinal Early-Onset Alzheimer's Disease Study, or LEADS, aims to provide a foundation that may lead to new therapies for the disease.

  • (Image courtesy of Endocyte)

    Endocyte Hits $1.5B Mark

    Purdue University says West Lafayette-based Endocyte Inc. (Nasdaq: ECYT) has become its first startup to reach $1.5 billion in value. The company says its drug platforms in various stages of development and clinical trials are showing promising results in treating conditions including advanced prostate cancer and pediatric bone cancer. Endocyte was founded in the Purdue Research Park, with most of its technology based on research by Purdue Presidential Scholar in Drug...

  • (Image courtesy of Eli Lilly and Co.)

    Lilly Migraine Treatment to Hit U.S. Market

    A preventative migraine treatment from Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has cleared a major hurdle. Emgality, a once-monthly injectable treatment, has received U.S. Food and Drug Administration approval. The pharmaceutical manufacturer says Emgality will be commercially available shortly and that a Medical Expenditures Panel Survey suggests costs in the U.S. associated with migraine total up to $56 billion a year. The disease affects 30 million adults in the country.

  • The winners will be announced at this year's Indiana Life Sciences Summit. (photo courtesy of BioCrossroads.)

    BioCrossroads Names Competition Finalists

    BioCrossroads has announced the finalists for its annual New Venture Competition and the inaugural digital health competition known as the Indiana Inject Tech Challenge. The state's life sciences initiative says the winners of both events will be announced at the 2018 Indiana Life Sciences Summit next month.

  • Frustration with the traditional inventory model during their orthopedic careers inspired RAM’s founders to  solve the problem.

    ‘Vision System’ Aims to Overhaul ‘Archaic’ Device Inventory Management

    After more than 20 years working for implant manufacturers and trying to unravel a muddled inventory system, leaders of a young Fort Wayne company believe their technology delivers a solution. 

  • Pinpoint Pharma (left) and Brightlamp are working with the Purdue Foundry to develop their technologies.

    Indiana Life Sciences Entrepreneurs Shine in Silicon Valley

    Eight Indiana-based early-stage startups took a trip to Silicon Valley to showcase Hoosier ingenuity, entrepreneurship and the state’s blossoming tech industry. The group, hosted by the Indiana Economic Development Corporation, set up shop in Startup Alley during the TechCrunch Disrupt SF Conference earlier this month in San Francisco. 

  • The school believes examining the skin disorder through an osteopathic lens will provide a unique perspective.

    First NIH Grant Boosts Marian’s Medical School

    A young medical school in Indiana is celebrating a National Institutes of Health (NIH) grant that will not only address a common skin condition, but also establish the university’s footing in nationally-recognized research. 

  • Nanovis makes nanotechnology-enhanced spinal implants.

    Indiana Investors Lead $5.5 Million Boost to Nanovis

    A Carmel-based company that says it makes “superior” spinal implants is celebrating a $5.5 million investment round and preparing to reveal its newest technology. 

  • (Image courtesy of Junior Achievement of Central Indiana.)

    Job Event For Students Aims to 'Spark' Enthusiasm

    An event this week in Indianapolis is providing over 9,000 central Indiana 8th graders with what organizers say is a first-hand look at potential future careers. JA JobSpark, an annual Junior Achievement of Central Indiana program, brings together students from 62 schools and representatives from 120 employers to take part in career exploration activities. JA of Central Indiana Chief Executive Officer Jennifer Burk says it's never too early to engage students in...

  • (photo courtesy Westgate@Crane Technology Park)

    Researchers Set For Inaugural Technology Showcase

    The Indiana Technology Showcase at the WestGate Academy will debut Tuesday in Odon. It will feature 30 researchers from the University of Notre Dame, Purdue University, Indiana University, University of Southern Indiana, Ivy Tech Community College and the Crane Naval Surface Warfare Center. Each will have three minutes to present their technologies, followed by time to discuss the innovations and potential licensing opportunities. The technology fields expected to be covered include...

  • Elanco was front and center Monday at the New York Stock Exchange. (photo courtesy NYSE)

    Elanco Rings Opening Bell at NYSE

    Officials from Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) rang the opening bell Monday at the New York Stock Exchange. The event marked the company's Initial Public Offering, which began last week.

  • (Image courtesy of IUPUI)

    Regenstrief, IU Aging Center Partner on First-of-Its-Kind Study

    Researchers at the Regenstrief Institute Inc. in Indianapolis and the Indiana University Center for Aging Research have received $3 million from the National Institute on Aging. The grant will cover five years and focus on studying the benefits and harms of Alzheimer's disease screenings for family members of likely caregivers should their older relatives be diagnosed with Alzheimer's. The institute and center say this type of research has never been conducted.

  • James Collins will be CEO of Corteva Agriscience.

    DowDuPont Announces Ag Leadership

    DowDuPont (NYSE: DWDP) has named the senior leaders for its agriculture division, which will be spun-off as a condition of the massive merger between Dow and DuPont. Corteva Agriscience, which officials say will have a significant presence at the Dow AgroSciences campus on the northwest side of Indianapolis, will be led by current ag division Chief Operating Officer James Collins. The merger of Dow and DuPont closed a year ago. Collins previously served as...

  • (Image courtesy of Elanco)

    Elanco Begins IPO

    Greenfield-based Elanco Animal Health Inc. (NYSE: ELAN) has begun its Initial Public Offering on the New York Stock Exchange. The company, which is being spun off from Indianapolis-based Eli Lilly and Co. (NYSE: LLY), is looking to raise more than $1.7 billion from the IPO.

  • (Image courtesy of WTC Indianapolis) Fahad Al Gergawi, pictured right next to Indiana Secretary of Commerce Jim Schellinger and Governor Eric Holcomb, met with business and economic leaders in Indianapolis.

    Dubai Trade Official Talks Indiana Opportunities

    An economic development official from the United Arab Emirates is using a trade mission in Indianapolis to showcase economic opportunities in Dubai. Dubai FDI Chief Executive Officer Fahad Al Gergawi said Indianapolis is one of more than a dozen U.S. cities he and his colleagues have toured in the last four years that possess "significant strength in terms of international trade." Al Gergawi estimates some $240 million in exports from Indiana maker their way to the UAE...

  • New IBRI Center to Focus on Diabetes

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) is teaming up with the Indiana Bioscience Research Institute and the Indiana University School of Medicine to create the Lilly Diabetes Center of Excellence. Lilly says the goal of the center is to establish a nexus of strategically-aligned basic diabetes research operations in Indy. The LDCE plans to recruit principal investigators to pursue cutting-edge research in diabetes, diabetic complications, and related metabolic disorders.

  • Before being loaded onto the drone, high-tech Helmer refrigerators ensure the blood stays within a very tight temperature range.

    Helmer Helping High-Tech Lifesaving Mission

    An Indiana company is playing a key role in a lifesaving mission in Africa. Noblesville-based Helmer Scientific, which makes medical-grade refrigerators, freezers and blood bank storage equipment, is working with a Silicon Valley company to deliver critical blood supplies to remote areas of Rwanda. Helmer is working with robotics company Zipline on the high-tech effort, which the Indiana company says specifically targets mothers that have bleeding issues while giving birth. During an...

  • The company's NSS-2 BRIDGE device helps to treat opioid withdrawal symptoms. (photo courtesy Innovative Health Solutions)

    Opioid Withdrawal Device Advances in Ohio Competition

    A Ripley County-based medical device company is among 12 to advance in a competition aimed at finding new solutions to combat the opioid addiction crisis. Innovative Health Solutions in Versailles has received $200,000 in funding for advancing to the second phase of the Ohio Opioid Technology Challenge.

  • Trade Officials From Dubai Heading to Indy

    A delegation of business, economic development and governmental officials from the United Arab Emirates will be in Indianapolis beginning Sunday. The visit, hosted by World Trade Center Indianapolis, will focus on boosting economic ties between the state and the Middle Eastern nation. WTC Indianapolis President Doris Anne Sadler told Inside INdiana Business international visits like this will attract additional visits. Interest in this event, she added, has already sparked...

  • (Image from Franciscan Health provided to the city of Carmel)

    Franciscan Health Eyes $130M Carmel Ortho Hospital

    Mishawaka-based Franciscan Health is planning a $130 million orthopedic hospital in Carmel. The proposed Franciscan Health Orthopedic Center of Excellence is expected to employ more than 430. The proposal is set to go before the city's plan commission September 18.

  • As part of its response, Cook realigned the company's business into two divisions.

    Cook Resolves 2014 FDA Warning Letter

    Bloomington-based Cook Medical says it has closed out the process of resolving a 2014 warning letter from the U.S. Food and Drug Administration involving documentation and data collection. Cook says the resolution is the result of "countless hours of hard work by hundreds of people" to improve its quality system. Cook Group and Cook medical President Pete Yonkman says the feedback from the FDA letter was "tough, but beneficial." As part of its response, Cook...

  • (Rendering courtesy of Ball State University.)

    Design Unveiled For Ball State Sciences Building

    Ball State University trustees have received the proposed design for a five-story, $87.5 million Foundational Sciences Building. The project, which is expected to take two years, could get underway next fall. The facility is the larger of two that will eventually replace the aging Cooper Science Complex as the primary homes of the university's science and health-based academic programs. The other piece, the $62.5 million Health Professions Building, is slated to open around...

  • Cook Biotech is located at the Purdue Research Park in West Lafayette.

    Cook Biotech Partnering with Massachusetts Company

    West Lafayette-based Cook Biotech Inc. is partnering with AcuityBio Inc. in Massachusetts to continue work on a lung cancer product. The companies say they will collaborate on the advancement of AcuityBio's ABC103, which will feature proprietary technology from Cook Biotech.

  • Elanco Releases Details on IPO

    Greenfield-based Elanco Animal Health Inc. has provided more details on its upcoming Initial Public Offering. The subsidiary of Eli Lilly and Co. (NYSE: LLY) has not yet released a date for the IPO, but says it will list its common stock on the New York Stock Exchange under the ticker symbol "ELAN."

  • (Image of interviewers Shannon, Dengke and Jaedyn courtesy of "State of Change.")

    Documentary to Feature Hoosier Students' Future-Shaping Journey

    A new documentary that follows the journey of three Indiana students interviewing professionals in some of Indiana's signature industries debuts Thursday. "State of Change" was produced in partnership with Roadtrip Nation, a national organization focused on career exploration. Some of the companies featured in interviews by the students include Scott Farms in Carroll and Cass counties, GE Aviation in Lafayette and Salesforce.com Inc. in Indianapolis.

  • Joseph Wallace (photo courtesy IUPUI)

    IUPUI Professor Lands $2M NIH Grant

    The National Institutes of Health has awarded a $2 million grant to an IUPUI professor. Joseph Wallace, associate professor of biomedical engineering, says the five-year grant will be used to research ways to build bone mass and improve bone quality in people with osteoporosis and diabetes.

  • White to Lead Lilly Oncology

    Indianapolis-based Eli Lilly and Co. (NYSE: LLY) has named Anne White president of Lilly Oncology. White will also serve as senior vice president for the parent company and will succeed Sue Mahony, who is retiring. White first came to Lilly in 1991 as an engineering before taking multiple clinical research and drug development positions inside and outside the company. She currently serves as...

  • (Rendering courtesy of Premier BioSource.)

    Research Swine Company Selects Jasper County

    An agbiosciences company from California has broken ground on its first Indiana operation. Premier BioSource, which raises swine for research purposes, plans to invest about $7.5 million into a 600-sow production facility in Rensselaer. The company says it considered other locations in Michigan and Illinois, but selected Indiana because of its business climate and financial strength. The operation is expected to be open within a year and employ 21 in Jasper County.

  • (Image courtesy of Roche Diagnostics.)

    Roche Academy Boasts Training, Job Offer

    Roche Diagnostics Corp. in Indianapolis, the University of Indianapolis and Ascend Indiana have announced a collaboration designed to fill high-need technical jobs at the biotechnology company. The Roche Academy will include customized curriculum and internships for UIndy biology and chemistry students which could lead to job offers from the company upon graduation. Recruiting efforts for the program are expected to begin in October and, once students complete...

  • Greenlight Guru employees celebrate a product launch.

    Medical Device Companies Put Greenlight Guru in Fast Lane

    They’re still out there, says Indianapolis-based Greenlight Guru: dusty corporate basements with 50 fireproof filing cabinets, storing medical device quality management paperwork held together with bubblegum, rubber bands and hot glue-gunning. 

  • Lee's discovery enables tiny sensors and devices to be placed on soft contact lenses.

    PU Discovery Enables ‘Smart’ Contact Lenses to Monitor Health

    A Purdue University researcher believes he’s on the way to creating high-tech contact lenses soldiers could wear for night vision. Another ambition is augmented reality, minus the bulky goggles.

  • The prestigious grant gives Broxmeyer freedom to seek the most promising path for cord blood transplant research.

    Legendary IU Researcher Aims to Break New Ground

    Cord blood stem cell transplants have saved the lives of countless children—more than 40,000—because of a discovery made at Indiana University School of Medicine (IUSM) in the 1980s, but like most science, it’s not perfect. 

  • Dr. Chandan Sen is the latest scientist recruited by the INCITE program.

    INCITE Attracts Another ‘Superstar,’ Adds Might to Precision Health

    The Indiana University Precision Health Initiative (PHI), now at the two-year mark, recently announced progress toward its goal to unleash the power of personalized medicine to cure one cancer and one childhood disease over the next decade. 

  • Indiana Popcorn Seed Maker Reaching Markets Worldwide

    A hybrid popcorn seed producer and distributor may be located in a small Tippecanoe County community, but it has built a global footprint. Romney-based Ag Alumni Seed sprouted from Purdue University in 1938 to market hybrid watermelon, tomato, grains and corn developed at the school and when the program ended in 1995, the nonprofit was born. Ag Alumni Seeds Agricultural Alumni Seed Improvement Association Inc., as it is formally known, has customers throughout...

  • (Image courtesy of Nanovis.)

    Medical Device Maker Secures $5.5M Funding Round

    A medical device manufacturer headquartered in Carmel has received a $5.5 million boost. The investment in Nanovis includes Indiana participants such as Indianapolis-based Elevate Ventures, 1st Source Capital Corp. in South Bend, the Purdue Research Foundation's Foundry Investment Fund -- launched as a partnership between PRF and Bloomington-based Cook Medical -- and Carmel-based Ellipsis Ventures. Commenda Capital LLC in Georgia also contributed. Nanovis says the funds will...

  • (Image courtesy of the Economic Development Coalition of Southwest Indiana.)

    AstraZeneca Makes Global Connections From Posey County

    The executive director of a major pharmaceutical site in Posey County is discussing its global reach. In a video from the Economic Development Coalition of Southwest Indiana profiling the AstraZeneca PLC manufacturing and distribution operation in Mount Vernon, Tanya Harris says about half of the products from the facility are exported throughout the world. The operation was acquired by AstraZeneca in late 2015 in a more than $3 billion deal for the global diabetes business...

  • (Image courtesy of the ETHOS Innovation Center.)

    ETHOS Center Boosts STEM Learning For Students, Teachers

    Students and teachers returning to class in Elkhart County have a new destination for science, technology, engineering and math learning opportunities. The $8.2 million ETHOS Innovation Center, which opened in April, is a hands-on museum and learning space located at a former Bayer Corp. pharmaceutical facility in Elkhart. The center features science camps in the summer months, during spring and fall breaks, after school and for field trips, as well as...

  • Chandan Sen will serve as the inaugural director of the center. (photo courtesy IU School of Medicine)

    IU Center to Focus on Regenerative Medicine

    The Indiana University School of Medicine has announced plans for a new center focused on regenerative medicine. IU will invest more than $20 million over the next five years to establish the Indiana Center for Regenerative Medicine and Engineering, specializing in what the university says is a rapidly-developing field. The center will be led by Chandan Sen, who previously served as director of the Center for Regenerative Medicine and Cell-Based Therapies at Ohio State University.

  • Acquisition Costs Lead to Loss for BASi

    West Lafayette-based Bioanalytical Systems Inc. (Nasdaq: BASI) is reporting a fiscal third quarter net loss of $75,000, compared to net income of $227,000 during the same period last year. Chief Financial Officer Jill Blumhoff says the earnings were negatively affected by costs related to the company's July acquisition of Missouri-based Seventh Wave Laboratories LLC. 

  • OrthoPediatrics went public in October 2017. (photo courtesy Nasdaq)

    OrthoPediatrics Growing in Warsaw

    Warsaw-based OrthoPediatrics Corp. (Nasdaq: KIDS) has announced plans to expand its Kosciusko County headquarters. The medical device manufacturer says it will invest $1 million to double the size of its existing warehouse and adding office space and dedicated training and education facilities.

  • (Image courtesy of the Office of Evansville Mayor Lloyd Winnecke.)

    'Once-in-a-Lifetime' Med Center Now Open

    More than seven years after the concept was first imagined, a process involving multiple institutions of higher learning, city and state leaders and the southwest Indiana medical community is complete. The $70 million Stone Family Center for Health Sciences in downtown Evansville is now open. Mayor Lloyd Winnecke said the campus evokes descriptions such as "enduring, generational (and) once-in-a-lifetime." During a recent interview...

  • Mark Throdahl is CEO of OrthoPediatrics. (photo courtesy Nasdaq)

    Despite Net Loss, OrthoPediatrics Hits Record Revenue

    Warsaw-based OrthoPediatrics Corp. (Nasdaq: KIDS) is reporting a second quarter net loss of $2.7 million, compared to a loss of $1.3 million during the same period last year. However, the pediatric medical device company is also reporting record quarterly revenue of $15.1 million.

  • (image courtesy of West.)

    Contract Pharma Facility Slated to Close

    Pennsylvania-based West Pharmaceutical Services Inc. says it plans to close its only Indiana operation. The Frankfort facility, which provides contract manufacturing, custom molding and assembly functions, currently employs 54. The global company says "virtually all" positions in Clinton County will be eliminated after October 1. Layoffs will take place in four groups through the end of November. In a notice to the state, West says the employees affected by the closing will...
  • (Image of Steven Becker courtesy of IU School of Medicine-Evansville.)

    Evansville Charity Boosts IU Med School

    Indiana University School of Medicine-Evansville has received a $2.5 million grant from the charitable arm of Evansville-based Koch Enterprises Inc. The gift will fund the associate dean and director of IUSM-Evansville position, which will be called the Koch Chair in Medicine. Steven Becker, who has served as the school's director, is the first to carry the new title. The school’s new home, the high-profile Stone Family Center for Health Sciences, will be dedicated next week.

  • The effort is led by IU Associate Vice President for Clinical Affairs Anantha Shekhar.

    IU Updates 'Precision Health' Challenge

    Two years in, Indiana University School of Medicine Dean Jay Hess says the school's first Grand Challenges initiative is "already impacting the care we provide patients." The $120 million Precision Health effort has goals including curing one cancer and one childhood disease over the next decade through a focus on individualized medicine. The school says it has recruited 33 new research faculty from throughout the country and will soon start canvassing Indiana for...

  • (Image courtesy of the University of Nebraska.)

    Corteva Agriscience Exec Receives Presidential Nomination

    President Donald Trump has nominated an Indiana agbiosciences executive to serve as the U.S. Department of Agriculture under secretary of agriculture for research, education and economics. Scott Hutchins is the global leader of integrated field sciences for Corteva Agriscience, which has a Global Business Center at the former Dow Agrosciences campus in Indianapolis. Hutchins is also an adjunct professor at the University of Nebraska and previously served as...

  • Wood Family Foundation Donates $2M to IU

    Lung cancer research received a boost in the form of a $2M gift to the Indiana University School of Medicine from the Tom and Julie Wood Foundation. The gift establishes the Tom and Julie Wood Family Foundation Chair in Lung Cancer Clinical Research and will fund new treatments to test in clinical trials, as well as serve as a catalyst for other efforts. The first chair is IU Professor and practicing oncologist Nasser Hanna. “I can’t even begin to tell you what ...

  • The program’s goals include helping doctors identify high-risk patients, increasing HIV screening and educating clinicians about HIV/AIDS resources around the state. (Courtesy: Centers for Disease Control and Prevention)

    Company Aims to Empower Docs to Deal with HIV

    The HIV outbreak in Indiana—fueled by the opioid epidemic—may seem insurmountable, but an Indianapolis-based company says it can be stopped, and it’s helping lead the charge. 

  • Lilly Extends Collaboration With Cancer Institute

    Eli Lilly and Company (NYSE: LLY) has announced a three-year extension of its collaboration with Dana-Farber Cancer Institute. Scientists from each organization have been working together on various cancer care elements since 2015. "This collaboration provides an opportunity for scientists and clinicians at a premier cancer center to bring creative new ideas about the underlying science and how this might drive future clinical opportunities for multiple Lilly therape...

  • Before being loaded onto the drone, high-tech Helmer refrigerators ensure the blood stays within a very tight temperature range.

    Helmer Keeps Blood Drone-Ready in Africa

    A lifesaving mission that delivers blood via drones is underway in Rwanda, and an Indiana company is a critical part of the operation. Silicon Valley-based robotics company Zipline launches high-tech drones into Rwanda’s sky each day, loaded with lifesaving blood for patients in remote areas. 

  • DK Pierce's office is in Zionsville at Creekside Corporate Park, which is designed to blur the line between the office and the great outdoors.

    DK Pierce: Nature Nurtures Company’s Growth

    A firepit crackles, dogs sniff out employees with treats and woodland trails beckon rejuvenating breaks; this is the idyllic workspace that Denise Pierce envisioned and is executing for her 20 employees as they tackle some of the toughest challenges in the demanding world of drug development. 

  • Pave says its full core biopsy device gives clinicians a smaller needle than ever before to collect lung biopsies.

    Pave Preps First-of-its-Kind Lung Biopsy Device

    Lung cancer is the leading cause of cancer death, and doctors are clamoring for a better way to diagnose it. A Zionsville-based startup is creating a lung biopsy device that it says gives clinicians something they’ve never had before: a smaller needle and a safer tissue-collection process that produces a clearer diagnosis for the patient. 

  • Life Sciences Video

    • BioCrossroads Looking to the Future During Transition

      The incoming interim president and chief executive officer of BioCrossroads says the transition in leadership will be a smooth one. The state's life science initiative announced Wednesday longtime CEO David Johnson is leaving to continue his role as CEO of the Central Indiana Corporate Partnership on a full-time basis. Nora Doherty will assume the interim position at the beginning of the year and says BioCrossroads continues to look to the future.

    • BioCrossroads Announces Watanabe Winner, New Seed Fund

      Indiana University Associate Vice President for Clinical Affairs Anantha Shekhar is the 2018 Watanabe Life Sciences Champion of the Year. BioCrossroads made the announcement today at its annual Life Sciences Summit in Indianapolis. Shekhar is leading the $120 million Precision Health Grand Challenges effort.

    More
  • Most Popular Stories

    • Chamber Unveils 'Best Places to Work'

      The Indiana Chamber of Commerce has released its list of the Best Places to Work in Indiana. This year's list features 125 companies throughout the state, including more than 40 that were not on the list last year. The chamber will unveil company rankings April 30 at an awards dinner at the Indiana Convention Center in downtown Indianapolis. Winners are sorted into four categories based on size. Out-of-state parent companies must have at least 15 full-time employees in Indiana to...

    • Public, Private Investment Driving Speedway Growth

      Speedway leaders say the town is full speed ahead with millions of dollars in public and private projects that will help change the landscape of the Marion County community. At the heart of them all, says Town Manager Jacob Blasdel, is the new Town Hall in an old PNC Bank building that will house all of Speedway's town offices. Also in the works are a recently-announced $8 million mixed-use proposal on Main Street from Rebar Development, the soon-to-open $36 million Wilshaw...

    • Indiana Rural School Clinic Network Expands to Pekin

      East Washington School Corp. has announced that East Washington Elementary School is now a participant in the Indiana Rural School Clinic Network. Supported by Ascension/St. Vincent Salem, the school now has a telehealth clinic available to its students and staff. 

    • The bill now moves to the Senate Appropriations Committee.

      Soccer Stadium Funding Added to CIB Bill

      The Indiana Senate Appropriations Committee has approved a bill that includes funding for a new soccer stadium in Indianapolis, however the stadium may not necessarily become home to the Indy Eleven. Our partners at WIBC report the bill authorizes financing for a stadium to host a Major League Soccer team; the Indy Eleven play in the United Soccer League. The bill also fund the expansion of the Indiana Convention Center and two hotels in downtown Indy, as well as extend the...

    • Kite FFO Dips, Plans to Sell Off Properties

      Indianapolis-based Kite Realty Group Trust (NYSE: KRG) is reporting full-year Funds from Operations of $167 million in 2018, down from $171 million the previous year. The company has also announced plans to offload up to $500 million in assets in an effort to reduce its debt.